Department of Chemical and Biomolecular Engineering Korea Advanced Institute of Science and Technology(KAIST) Youseonggu Guseongdong 335 Daejeon Korea;
Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 40 Blossom St, Boston, MA 02114;
Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 40 Blossom St, Boston, MA 02114;
Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 40 Blossom St, Boston, MA 02114;
Ovarian Cancer; Photodynamic Therapy; EtNBS, Hypoxia;
机译:PLGA纳米颗粒封装可降低毒性,同时保留EtNBS-PDT的体外治疗功效
机译:光动力疗法激活了表皮生长因子受体和STAT3的信号转导:靶向生存途径以提高PDT在卵巢癌和肺癌中的疗效
机译:基于SILAC的定量蛋白质组学将溶酶体确定为对PDT剂Gd-N诱导的人卵巢癌IGROV1细胞氧化应激的快速反应靶标
机译:基于光漂白的PDT剂量指标可预测卵巢癌三维模型中某些BPD浓度范围内的PDT功效
机译:光动力疗法(PDT)对表皮生长因子受体和白介素6细胞因子信号转导的影响,酪氨酸激酶抑制剂通过增加光敏剂在细胞内的积累来增强PDT的功效。
机译:PLGA纳米颗粒封装可降低毒性同时保留EtNBS-PDT的体外治疗功效
机译:pLGa纳米颗粒包封降低了毒性,同时在体外保留了EtNBs-pDT的治疗功效